EWI2/PGRL associates with the metastasis suppressor KAI1/CD82 and inhibits the migration of prostate cancer cells.

Xin A. Zhang(University of Oklahoma Health Sciences Center), Lei Liu(Army Medical University), Eric Rubinstein(Centre National de la Recherche Scientifique), Stéphanie Charrin(Hôpital Paul-Brousse), William S. Lane(Brigham and Women's Hospital)
PubMed
May 15, 2003
Cited by 106


Related Papers